A study examining the eyes of 1,400 Hong Kong children has a drawn a link between secondhand smoke and eye damage.
Australian genetics study paves way for glaucoma blood test
Australian researchers have identified 107 genes that increase the risk of glaucoma and developed a genetic test to detect people at risk of going blind from the condition. Read more
Australian bionic eye to take on the world
Australia-based research into bionic eye technology is expanding internationally, with global tests planned after the successful results of a four-patient trial in Melbourne. Read more
Aussie researchers uncover faster, cheaper test for myopia
South Australian researchers have developed a new method to assess myopia using optical coherence tomography (OCT). Read more
Government pushes ocular projects for commercial development
Projects to develop decision support software for macular disease, sustained release ocular implants and a control sleeve for intravitreal injections are a step closer to commercial development, following the latest round of government research grants. Read more
Opthea hits recruitment target for diabetic study
Melbourne biopharmaceutical company Opthea has completed the patient recruitment phase for the latest trial of its novel therapy for diabetic macular edema (DME). Read more
Sleep apnoea linked to diabetic macular oedema
New research has drawn a link between severe sleep apnoea and diabetic macular oedema, firming up the connection between the two conditions.
Genes from archaea used to prevent blindness
By combining archaea and mammal DNA, researchers are hoping to ‘bypass evolution’ and give people genes that would allow them to resist retinal degeneration.
New type of tissue found in the eye
Researchers have found cellular components in the epithelial tissue of the eye that were previously only thought to be present in electrically active tissues. It is hoped the discovery could lead to new treatments for diseases that are currently incurable.
New eye models allow for better drug development
A newly detailed model for cultivating retinal pigment cells could make the development of new and improved ocular drugs significantly easier. Read more